speb/financial-data huggingface dataset:
BLDP.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -162808000.00
BLDP.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -162808000.00
BLDP.TO cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 14788000.00
BLDP.TO balance_sheet (annual, 2024-12-31) — Work In Process: 6622000.00
BLDP.TO balance_sheet (quarterly, 2024-12-31) — Work In Process: 6622000.00
BLDP.TO balance_sheet (annual, 2024-12-31) — Working Capital: 623292000.00
BLDP.TO income_statement (annual, 2024-12-31) — Write Off: 12760000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 25225000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 15389000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 21705000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 20773000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 309491000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -4965000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 125000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 125000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 689000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 299518254.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.07
BLDP.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 603948000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -2663000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 23262000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2430439000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 576698000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 578802000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -689000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -2735000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -24403000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -8752000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 2776000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: -2303000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -2303000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 1791000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 3768000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2720000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -27827000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 2430439000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 653821000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 18997000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 675120000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 3025000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 3025000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 9150000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 9150000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 74991000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Current Provisions: 26348000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 861000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 985000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 985000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 299518254.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.07
BLDP.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -21036000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — EBIT: -20530000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — EBITDA: -19545000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -818000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 818000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 577000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 576698000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -689000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: -4236000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -27066000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -437000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 70000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 11321000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -4236000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4665000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1865000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 25738000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 29563000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Gross Profit: -3608000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 2223000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 506000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 506000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 65117000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 653821000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -2735000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 42113000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 49578000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 7465000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Leases: 23945000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 20237000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 20237000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -689000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 7465000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 4038000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Net Income: -21036000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -21036000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -21036000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -21036000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -21036000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -21036000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -21036000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -233000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -326000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -152000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -689000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -689000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -326000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 80000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 29563000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2430000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 651956000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4866000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 4866000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -28486000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -29977000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -24403000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 309000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Operating Income: -28833000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 15389000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 299833234.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3083000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 4539000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 4665000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 8123000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1865000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -50000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 484000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 2695000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Other Payable: 9610000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 1580000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 7345000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2104000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Other Taxes: -180000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Payables: 31929000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 31929000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: -2000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -21036000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -233000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -152000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2430000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 28118000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 18997000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 985000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -689000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Research And Development: 18105000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 228000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -2081873000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 2455000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 7120000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 299833234.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -2380000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1866000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 653821000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 651956000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 756610000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 653821000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 23262000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 653821000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 44222000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 102789000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 81490000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 27798000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -29060000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -180000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 614000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 8941000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 8941000.00
BLDP.TO cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -4446000.00
BLDP.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 600129000.00
BLDP.TO income_statement (quarterly, 2025-03-31) — Write Off: -1000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 25363000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 17842000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 19214000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 15872000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 314007000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -2940000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 204000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 204000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 698000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 45871000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 299844902.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.08
BLDP.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 576698000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2340000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 23726000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2430628000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 550035000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 552145000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -797000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -7051000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -20335000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -4827000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 1791000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: -848000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -848000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 427000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 3947000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 490000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -28183000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 2430628000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 635946000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 19337000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 647320000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3245000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3245000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 8578000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 8578000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 69539000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Current Provisions: 24230000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 759000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 964000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 964000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 299844902.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.08
BLDP.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -24280000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — EBIT: -23758000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — EBITDA: -22794000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -444000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 444000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 1520000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 87000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 550035000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -797000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: -2536000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -22675000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -249000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 3000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 10822000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2536000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4788000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1765000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 18812000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 28897000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Gross Profit: -1495000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 939000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 498000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 498000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 68872000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 635946000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -7051000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 45871000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 57367000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 4278000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 7218000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Leases: 23210000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 20481000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 20481000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -797000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 11496000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 2745000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 4027000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Net Income: -24280000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -24280000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -24280000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -24280000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -24280000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -24280000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -24280000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -104000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -498000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -4711000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -797000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -797000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -498000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 0.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 28897000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2236000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 634181000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 7058000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 7058000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -26338000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -27292400.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -20335000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 183000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Operating Income: -26858000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 17842000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 299868076.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 2882000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 4238000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 4788000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 3100000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1765000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 146000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 507000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Other Payable: 9274000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 1660000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 7549000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 2110000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Payables: 29248000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 29248000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: -9000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -24256000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -104000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -4711000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2236000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 23421000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 19337000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 964000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -797000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Research And Development: 18176000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 5851000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -2106153000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 2399000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 7187000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 299868076.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -7278000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 4789000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 635946000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 634181000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 531600.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 24000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 735856000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 635946000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 23726000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 635946000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 44700000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 99910000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 88536000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 30371000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -33200000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 760000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 3544000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 3544000.00
BLDP.TO cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -3325000.00
BLDP.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 577781000.00
BLDP.TO income_statement (quarterly, 2025-06-30) — Write Off: 491000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 17239000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 32501000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 18023000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 28075000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 310361000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -2980000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 217000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 217000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: -1643000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 45746000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 300512149.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.09
BLDP.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 550035000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1397000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 22561000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2432404000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 525744000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 527852000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -740000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1426000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -22857000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: 7484000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 1667000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 3796000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 3796000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -404000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -9058000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 3485000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -25023000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 2432404000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 606824000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 27539000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 623449000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 3278000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3278000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 10856000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 10856000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 74810000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Current Provisions: 27720000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 818000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1035000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1035000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 300512149.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.09
BLDP.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -28070000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — EBIT: -27617000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — EBITDA: -26582000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -1895000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 1895000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 732000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 87000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 525744000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -740000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: -1717000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -24254000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 1000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 0.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 4222000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -1717000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4158000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1548000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 31055000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 30287000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 4962000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 453000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 453000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 59871000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 606824000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1426000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 45746000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 54681000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 3516000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 5419000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Leases: 22544000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 19283000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 19283000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -740000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 8935000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 2682000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 4046000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Net Income: -28070000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -28070000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -28070000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -28070000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -28070000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -28071000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -28070000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: 0.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -461000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -29000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -740000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -740000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -461000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 30287000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1397000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 605276000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 6777000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 6777000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -13145000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -14633000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -22857000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 1896000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Operating Income: -12277000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 32501000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 300581918.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3294000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 4747000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 4158000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -15332000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1548000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -63000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 498000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Other Payable: 9993000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 3697000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 4357000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 2108000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Payables: 28209000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 28209000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: 0.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -28070000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: 0.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -29000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1397000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 32432000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 27539000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1035000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -740000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Research And Development: 11522000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 17618000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -2134224000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1559000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5717000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 300581918.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: -17659000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: -412000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 606824000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 605276000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 710463000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 606824000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 22561000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 606824000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 44778000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 103639000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 87014000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 28829000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -29936000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 8000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 193000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -13437000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -13437000.00
BLDP.TO cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 916000.00
BLDP.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 548639000.00
BLDP.TO income_statement (quarterly, 2025-09-30) — Write Off: 41000.00
BLDP.TO income_statement (annual, 2025-12-31) — +Operating Expense: 85237000.00
BLDP.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 17410000.00
BLDP.TO income_statement (annual, 2025-12-31) — +Total Revenue: 99370000.00
BLDP.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 33638000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 12007000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 12007000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 20765000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 20765000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -200518000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -200518000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 310041000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 310041000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2946000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2946000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 3935000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 4191000.00
BLDP.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 303000000.00
BLDP.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 291666667.00
BLDP.TO income_statement (annual, 2025-12-31) — Basic EPS: -0.30
BLDP.TO income_statement (quarterly, 2025-12-31) — Basic EPS: -0.06
BLDP.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 603948000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 525744000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -10181000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -3781000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 22140000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 22140000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 2433244000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2433244000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 527052000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 527052000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 531254000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 531254000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2584000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -358000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -20941000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -9729000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -56167000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 11428000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Change In Inventory: 10069000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 16164000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 7366000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 1132000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Change In Payable: -8326000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: -8971000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -8326000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -8971000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 2893000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 1079000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Change In Receivables: 6046000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 7389000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 18048000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 16793000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -79692000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 1341000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Common Stock: 2433244000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 2433244000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 589930000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 589930000.00
BLDP.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 93908000.00
BLDP.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 28035000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Current Assets: 601433000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 601433000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 3412000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 3412000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 3412000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 3412000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 8408000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 8408000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 8408000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 8408000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 60994000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 60994000.00
BLDP.TO balance_sheet (annual, 2025-12-31) — Current Provisions: 20386000.00
BLDP.TO balance_sheet (quarterly, 2025-12-31) — Current Provisions: 20386000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 4127000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1143000.00
BLDP.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 4127000.00
BLDP.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1143000.00
BLDP.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 303000000.00
BLDP.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 291666667.00
BLDP.TO income_statement (annual, 2025-12-31) — Diluted EPS: -0.30
BLDP.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.06
BLDP.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -90914000.00
BLDP.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -17527000.00
BLDP.TO income_statement (annual, 2025-12-31) — EBIT: -88958000.00
BLDP.TO income_statement (quarterly, 2025-12-31) — EBIT: -17049000.00
BLDP.TO income_statement (annual, 2025-12-31) — EBITDA: -84831000.00